Financial Highlights

-- Record levels of contracted sales in the year totaling $43.2m (FY08:

$25.7m), 68% up from the previous year, contributing to:

-- 23% increase in revenues to $23.0m (FY08: $18.7m)

-- 51% increase in future revenues under contract to $60.1m

(FY08:$39.9m)

-- Profit before share based payments, depreciation and amortization

increased 29% to $5.8m (FY08: $4.5m)

-- Profit before taxation increased by 40% to $5.9m (FY08: $4.2m)

-- Cash position increased 24% to $26.1m (FY08 $21.1m)

-- Basic EPS increased to $0.18 (FY08: $0.14) and diluted to $0.17 (FY08:

$0.13)

-- Final dividend proposed of 2.9p (4.77 cents) per share giving a total

dividend for the year of 4.7p (7.43 cents) per share (FY08: 3.1p (4.96

cents) per share)

Operational Highlights

-- New product lines contributed $10.1m (23%) to total contracted sales

during the year

-- Extended market reach through partnership deals with Premier, Amerinet

and Perot

-- Signed significant reseller agreement with McKesson Corporation post

year-end

-- Accelerated investment in sales and marketing activities

-- Proposed U.S. Healthcare reforms trend toward increased regulation and

new market opportunities

Keith Neilson, CEO of Craneware, commented, "The U.S. healthcare system is currently undergoing an unprecedented level of change and public scrutiny. This combined with the global economic downturn means healthcare organizations are experiencing extraordinary levels of fiscal and legislative pressure. Craneware continues to invest in the development and deployment of software to help manage these pressures and we believe that our market leading position and reputation within the industry, combined with our strong business fundamentals, leaves us well positioned to serve this growing demand.

"The signing of a significant value-added reseller agreement with McKesson Corporation, the world's largest healthcare services company, at the beginning of this new fiscal year has given us a strong start. The agreement sees McKesson integrate Craneware's Chargemster Toolkit(R) software with their next generation hospital information system (HIS), Horizon Enyterprise Revenue Management(TM) as part of their ongoing legacy system replacement and upgrading program. This new agreement, combined with a growing Craneware sales pipeline and the launch of further products by the end of the current year, gives us confidence we are on track to continue our history of significant growth in the year ahead."

About Craneware

Craneware (AIM: CRW.L) partners with healthcare organizations to improve returns, increase productivity and manage risk, driving sustainable financial and operational performance improvements using market-led revenue management solutions. By enhancing revenue capture processes, Craneware SaaS solutions allow those organizations to optimize reimbursement, improve operational efficiency, and support compliance. Visit craneware.com.

A full copy of the Company's Year-End Results can be found on Craneware's Web site at http://craneware.com. In the Investors area of the Web site, click on Financial Reports.

This document does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for Ordinary Shares in any jurisdiction in which such offer or solicitation is unlawful.

SOURCE Craneware, Inc.

Originally published by Craneware, Inc..

(c) 2009 PRNewswire. Provided by ProQuest LLC. All rights Reserved.

A service of YellowBrix, Inc.